Return to search

Avrio Backs Origin BioMed

Origin BioMed secured $3.8 million in a funding round led by Calgary-based Avrio Ventures joined by NSBI Venture Capital. The funding will be used to expand the company's over-the-counter topical drugs range into the US market. www.originbiomed.com